Browse by all authors Browse By Author ID - Paczkowski, Filip A.

Browse Results (16 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Paczkowski, FA, Bauman, S, Sharpe, LA, Dutertre, S and Lewis, RJ (2007). A conopeptide view of the norepinephrine transporter (NET), an integral membrane Na+- and CI-dependent transporter.. In: Biophysical Journal: 51st Annual Meeting of the Biophysical Society. 51st Annual Meeting of the Biophysical Society, Baltimore, (264A-264A). 3-7 March 2007. 86   0
Paczkowski, FA and Bryan-Lluka, LJ (2002) Amino Acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters. Naunyn-Schmiedeberg's Archives of Pharmacology, 365 4: 312-317. doi:10.1007/s00210-002-0528-z 64   6 Cited 6 times in Scopus6 0
Bryan-Lluka, L. J., Bonisch, H. and Paczkowski, F. A. (2001). A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .. In: British Journal of Pharmacology. British Pharmacological Society Meeting, United Kingdom, (17-17). 5-7 September, 2001. 87   0
Porzgen, P., Bryan-Lluka, L. J., Paczkowski, F. A., Bruss, M. and Bonisch, H. (1999) Characterisation of the recently cloned rat noradrenaline transporter - Comparison with bovine and human transporters. The Journal of Pharmacology and Experimental Therapeutics, 356 1: 81-81. 66   0
Paczkowski, Filip A., Sharpe, Iain A., Dutertre, Sébastien and Lewis, Richard J. (2007) chi-conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model. Journal of Biological Chemistry, 282 24: 17837-17844. doi:10.1074/jbc.M610813200 114   33 Cited 35 times in Scopus35 0
Paczkowski, F. A., Bryan-Lluka, L. J., Porzgen, P., Bruss, M. and Bonisch, H. (1999) Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. The Journal of Pharmacology and Experimental Therapeutics, 290 2: 761-767. 76   38
Bryan-Lluka, Lesley J., Paczkowski, Filip A. and Bonisch, Heinz (2001) Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. Neuropharmacology, 40 4: 607-617. doi:10.1016/S0028-3908(00)00201-X 69   15 Cited 17 times in Scopus17 0
Paczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2003). Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocaine. In: Journal of Psychopharmacology. Summer Meeting of the British Association for Psychopharmacology, Cambridge, England, (A80-A80). 20-23 July 2003. 51   0
Sucic, Sonja, Paczkowski, Filip A., Runkel, Fabian, Bonisch, Heinz and Bryan-Lluka, Leslie J. (2002) Functional significance of a highly conserved glutamate residue of the human noradrenaline transportere. Journal of Neurochemistry, 81 2: 344-354. doi:10.1046/j.1471-4159.2002.00826.x 71   11 Cited 13 times in Scopus13 0
Paczkowski, F. A., Wanstall, J. C. and Lluka, L.J. (2004). How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?. In: Warwick P. Anderson, Abstracts of the 8th World Congress on Clinical and Experimental Pharmacology & Therapeutics. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, (A190-A190). 1-6 August 2004. 47  
Bryan-Lluka, Lesley J., Papacostas, Marisa H., Paczkowski, Filip A. and Wanstall, Janet C. (2004) Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT). British Journal of Pharmacology, 143 1: 63-70. doi:10.1038/sj.bjp.0705904 86   22 Cited 20 times in Scopus20 0
Paczkowski, Filip A., Bonisch, Heinz and Bryan-Lluka, Lesley J. (2002) Pharmacological properties of the naturally occurring Ala457Pro variant of the human norepinephrine transporter. Pharmacogenetics, 12 2: 165-173. doi:10.1097/00008571-200203000-00010 74 4 12 Cited 13 times in Scopus13 0
Paczkowski, FA and Bryan-Lluka, LJ (2004) Role of proline residues in the expression and function of the human noradrenaline transporter. Journal of Neurochemistry, 88 1: 203-211. doi:10.1046/j.1471-4159.2003.02149.x 48   6 Cited 7 times in Scopus7 0
Paczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2001). Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter. In: T. Nagatsu, D.S. Goldstein and R. McCarthy, Proceedings of the 9th International Catecholamine Symposium. The 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, (65-65). 31 March - 5 April 2001. 50  
Dekan, Z., Paczkowski, F. A., Lewis, R. J and Alewood, P. F. (2007) Synthesis and In vitro biological activity of cyclic lipophilic χ-conotoxin MrIA analogues. International Journal of Peptide Research And Therapeutics, 13 1-2: 307-312. doi:10.1007/s10989-007-9083-2 74   7 Cited 8 times in Scopus8 0
Paczkowski, Filip A. and Bryan-Lluka, Lesley J. (2001) Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology. Molecular Brain Research, 97 1: 32-42. doi:10.1016/S0169-328X(01)00295-9 52   7 Cited 17 times in Scopus17 0